Community health a field of public health, is a discipline that concerns itself with the study and betterment of the health characteristics of biological communities.

Chubby Children and Fatty Liver Disease

One of my colleagues is a well know nutrition expert in the UK. He addresses many of the same issues I do here in Natural Health News. In a recent newsletter he addresses the issue of childhood obesity but directs the concern to food.

Half a million children have fatty liver disease

New shocking figures from the Government suggest that with 30% of children obese around 500,000 of those aged four to 14 could be suffering from liver disease. Non-alcoholic liver disease is caused by a build-up of fat within liver cells, stopping the organ functioning properly. This can lead to serious health problems with many requiring liver transplants. The problem is expected to escalate with experts predicting that by 2050, 63% of children will be obese. Professor Martin Lombard at the Department of Health warns that fatty liver disease could be a silent killer among this generation of children.

As well as fatty liver disease, childhood obesity is linked to many health concerns including diabetes, heart disease and cancer. The biggest factor is indisputably diet. Surveys show that the average Brit is eating only half of their recommended five portions of fruit and vegetables a day – with many children not even getting that. The worry is what they are eating in their place. Refined carbohydrates (sugary cereals, white bread, fizzy drinks, sweets and processed foods) now make up a large percentage of the diet for many.

The antidote is choosing wholegrain carbs and balancing your intake with protein and plenty of nutrient-rich fruit and vegetables. Swapping a few common foods for healthier options can make a marked difference, for example, fizzy drinks for fruit juice diluted 50/50 with sparkling water, turkey or chicken nuggets for salmon fish fingers, crisps for unsalted raw nuts or seeds.

While I agree that food is a mjor vector in the obesity epidemic, I also believe that the factors of vaccines, and specific vaccines, also play a major role in this public health outrage. I see vaccines as sort of the fuse to the dynamite. Hep B vaccine is also linked to Diabets Type 1 (on the rise) and may be a cause in childhood arthritis (see adverse reactions).

If you look at vaccine ingredients you often find MSG. Who knows why this needs to be in a vaccine but it is notable when you consider that MSG is linked to obesity, and food allergy as well.

Food allergy, or as Dr Hoffer might have said, brain inflammation, is an issue in obesity.

Recombivax is made in yeast, and it is carried in a solution that contains aluminum. We know from good science that aluminum compounds cause brain inflammation.

Side effects of the vaccine include elevated liver enzymes and this may correlate to the shutting down of the liver in fact given this jab very soon after birth. Certainly the question of "experimental" can be and shouldbe considered.

RECOMBIVAX (hepatitis b vaccine (recombinant)) HB and RECOMBIVAX (hepatitis b vaccine (recombinant)) HB Dialysis Formulation are generally well-tolerated. No adverse experiences were reported during clinical trials which could be related to changes in the titers of antibodies to yeast. As with any vaccine, there is the possibility that broad use of the vaccine could reveal adverse reactions not observed in clinical trials.

In three clinical studies, 434 doses of RECOMBIVAX (hepatitis b vaccine (recombinant)) HB, 5 mcg, were administered to 147 healthy infants and children (up to 10 years of age) who were monitored for 5 days after each dose. Injection site reactions and systemic complaints were reported following 0.2% and 10.4% of the injections, respectively. The most frequently reported systemic adverse reactions ( > 1% injections), in decreasing order of frequency, were irritability, fever ( ≥ 101°F oral equivalent), diarrhea, fatigue/weakness, diminished appetite, and rhinitis.10

In a study that compared the three-dose regimen (5 mcg) with the two-dose regimen (10 mcg) of RECOMBIVAX (hepatitis b vaccine (recombinant)) HB in adolescents, the overall frequency of adverse reactions was generally similar.

In a group of studies, 3258 doses of RECOMBIVAX (hepatitis b vaccine (recombinant)) HB, 10 mcg, were administered to 1252 healthy adults who were monitored for 5 days after each dose. Injection site reactions and systemic complaints were reported following 17% and 15% of the injections, respectively. The following adverse reactions were reported:

The following additional adverse reactions have been reported with use of the marketed vaccine. In many instances, the relationship to the vaccine was unclear.

Hypersensitivity

Anaphylaxis and symptoms of immediate hypersensitivity reactions including rash, pruritus, urticaria, edema, angioedema, dyspnea, chest discomfort, bronchial spasm, palpitation, or symptoms consistent with a hypotensive episode have been reported within the first few hours after vaccination. An apparent hypersensitivity syndrome (serum-sickness-like) of delayed onset has been reported days to weeks after vaccination, including: arthralgia/arthritis (usually transient), fever, and dermatologic reactions such as urticaria, erythema multiforme, ecchymoses and erythema nodosum (see WARNINGS and PRECAUTIONS).

The following adverse reaction has been reported with another Hepatitis B Vaccine (Recombinant) but not with RECOMBIVAX (hepatitis b vaccine (recombinant)) HB: keratitis.

Patients, parents and guardians should be instructed to report any serious adverse reactions to their healthcare provider, who in turn should report such events to the U.S. Department of Health and Human Services through the Vaccine Adverse Event Reporting System (VAERS), 1-800-822-7967.31

It is known to inhibit the synthesis of estradiol and other steroid hormones and can lead to infertility, reproductive problems, thyroid and pancreas and promote fatty liver as well as breast cancer. Soy can also interfere with protein ...

Their weight, cholesterol and blood pressure dropped, and levels of liver enzymes linked to "fatty liver" disease, the forerunner of cirrhosis, also fell away. Lead researcher Professor Bankole Johnson said: "What we've found is that ...